HERON THERAPEUTICS, INC. /DE/ Stock-Based Compensation
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Stock-Based Compensation of $6.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $3.18M, a 13.62% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.98M, a 18.52% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.18M, a 5.05% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.85M, a 4.78% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for fiscal 2025 was $10.34M, a 20.24% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for fiscal 2024 was $12.96M, a 60.55% decline from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for fiscal 2023 was $32.85M, a 23.56% decline from fiscal 2022.
- HERON THERAPEUTICS, INC. /DE/ share-based payment arrangement, noncash expense for fiscal 2022 was $42.98M, a 8.26% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $6.15M 10-Q · filed 2026-08-10 | $8.33M derived: sum of 3 quarters · filed 2026-08-10 | $11.19M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $2.98M 10-Q · filed 2026-05-11 | $5.16M derived: sum of 2 quarters · filed 2026-05-11 | $8.01M derived: sum of 3 quarters · filed 2026-05-11 | $10.80M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.03M derived: sum of 2 quarters · filed 2026-02-26 | $7.83M derived: sum of 3 quarters · filed 2026-08-10 | $10.34M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $5.65M derived: sum of 2 quarters · filed 2026-08-10 | $8.16M 10-Q · filed 2025-11-04 | $10.46M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $5.31M 10-Q · filed 2026-08-10 | $7.60M derived: sum of 3 quarters · filed 2026-08-10 | $10.32M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.51M 10-Q · filed 2026-05-11 | $4.81M derived: sum of 2 quarters · filed 2026-05-11 | $7.53M derived: sum of 3 quarters · filed 2026-05-11 | $12.10M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.02M derived: sum of 2 quarters · filed 2026-02-26 | $9.59M derived: sum of 3 quarters · filed 2026-02-26 | $12.96M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.29M derived: sum of 2 quarters · filed 2025-11-04 | $10.67M 10-Q · filed 2025-11-04 | $14.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $7.95M 10-Q · filed 2025-08-08 | $12.27M derived: sum of 3 quarters · filed 2026-02-26 | $18.95M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $3.38M 10-Q · filed 2025-05-06 | $7.70M derived: sum of 2 quarters · filed 2026-02-26 | $14.38M derived: sum of 3 quarters · filed 2026-02-26 | $28.28M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.01M derived: sum of 2 quarters · filed 2026-02-26 | $24.91M derived: sum of 3 quarters · filed 2026-02-26 | $32.85M 10-K · filed 2026-02-26 |
| 2023-09-30 | $6.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $20.58M derived: sum of 2 quarters · filed 2024-11-12 | $28.53M 10-Q · filed 2024-11-12 | $39.04M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $13.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $21.85M 10-Q · filed 2024-08-06 | $32.36M derived: sum of 3 quarters · filed 2025-02-27 | $43.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $7.95M 10-Q · filed 2024-05-07 | $18.46M derived: sum of 2 quarters · filed 2025-02-27 | $29.66M derived: sum of 3 quarters · filed 2025-02-27 | $40.01M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $10.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $21.71M derived: sum of 2 quarters · filed 2025-02-27 | $32.06M derived: sum of 3 quarters · filed 2025-02-27 | $42.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | $11.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $21.55M derived: sum of 2 quarters · filed 2023-11-14 | $32.47M 10-Q · filed 2023-11-14 | $45.35M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $10.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $21.27M 10-Q · filed 2023-08-14 | $34.16M derived: sum of 3 quarters · filed 2023-08-14 | $45.39M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $10.91M 10-Q · filed 2023-05-11 | $23.80M derived: sum of 2 quarters · filed 2023-05-11 | $35.04M derived: sum of 3 quarters · filed 2023-05-11 | $46.28M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $12.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $24.12M derived: sum of 2 quarters · filed 2023-03-29 | $35.37M derived: sum of 3 quarters · filed 2023-03-29 | $46.85M 10-K · filed 2023-03-29 |
| 2021-09-30 | $11.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $22.48M derived: sum of 2 quarters · filed 2022-11-08 | $33.96M 10-Q · filed 2022-11-08 | $50.00M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $11.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $22.73M 10-Q · filed 2022-08-09 | $38.76M derived: sum of 3 quarters · filed 2022-08-09 | $49.86M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $11.49M 10-Q · filed 2022-05-09 | $27.52M derived: sum of 2 quarters · filed 2022-05-09 | $38.62M derived: sum of 3 quarters · filed 2022-05-09 | $49.73M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $16.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $27.13M derived: sum of 2 quarters · filed 2022-02-28 | $38.24M derived: sum of 3 quarters · filed 2022-02-28 | $50.22M 10-K · filed 2022-02-28 |
| 2020-09-30 | $11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $22.21M derived: sum of 2 quarters · filed 2021-11-03 | $34.18M 10-Q · filed 2021-11-03 | $45.28M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $11.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $23.09M 10-Q · filed 2021-08-09 | $34.19M derived: sum of 3 quarters · filed 2022-02-28 | $43.89M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $11.97M 10-Q · filed 2021-05-10 | $23.07M derived: sum of 2 quarters · filed 2022-02-28 | $32.78M derived: sum of 3 quarters · filed 2022-02-28 | $45.48M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $20.80M derived: sum of 2 quarters · filed 2022-02-28 | $33.51M derived: sum of 3 quarters · filed 2022-02-28 | $51.41M 10-K · filed 2022-02-28 |
| 2019-09-30 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $22.41M derived: sum of 2 quarters · filed 2020-11-05 | $40.31M 10-Q · filed 2020-11-05 | $50.11M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $12.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $30.61M 10-Q · filed 2020-08-05 | $40.40M derived: sum of 3 quarters · filed 2021-02-24 | $48.45M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $17.90M 10-Q · filed 2020-05-06 | $27.70M derived: sum of 2 quarters · filed 2021-02-24 | $35.75M derived: sum of 3 quarters · filed 2021-02-24 | $43.57M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $17.84M derived: sum of 2 quarters · filed 2021-02-24 | $25.67M derived: sum of 3 quarters · filed 2021-02-24 | $33.37M 10-K · filed 2021-02-24 |
| 2018-09-30 | $8.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $15.87M derived: sum of 2 quarters · filed 2019-11-12 | $23.57M 10-Q · filed 2019-11-12 | $30.46M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $7.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $15.52M 10-Q · filed 2019-08-05 | $22.41M derived: sum of 3 quarters · filed 2020-03-02 | $29.89M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $7.70M 10-Q · filed 2019-05-09 | $14.59M derived: sum of 2 quarters · filed 2020-03-02 | $22.07M derived: sum of 3 quarters · filed 2020-03-02 | $30.22M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $6.89M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $14.37M derived: sum of 2 quarters · filed 2020-03-02 | $22.52M derived: sum of 3 quarters · filed 2020-03-02 | $30.54M 10-K · filed 2020-03-02 |
| 2017-09-30 | $7.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $15.63M derived: sum of 2 quarters · filed 2018-11-07 | $23.65M 10-Q · filed 2018-11-07 | $30.91M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $8.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $16.17M 10-Q · filed 2018-08-08 | $23.43M derived: sum of 3 quarters · filed 2019-02-22 | $30.94M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | $8.02M 10-Q · filed 2018-05-10 | $15.28M derived: sum of 2 quarters · filed 2019-02-22 | $22.79M derived: sum of 3 quarters · filed 2019-02-22 | $28.62M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $14.77M derived: sum of 2 quarters · filed 2019-02-22 | $20.60M derived: sum of 3 quarters · filed 2019-02-22 | $25.96M 10-K · filed 2019-02-22 |
| 2016-09-30 | $7.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $13.34M derived: sum of 2 quarters · filed 2017-11-06 | $18.70M 10-Q · filed 2017-11-06 | $24.55M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $5.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $11.19M 10-Q · filed 2017-08-09 | $17.03M derived: sum of 3 quarters · filed 2018-02-27 | $19.86M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $5.36M 10-Q · filed 2017-05-10 | $11.20M derived: sum of 2 quarters · filed 2018-02-27 | $14.02M derived: sum of 3 quarters · filed 2018-02-27 | $17.16M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $8.67M derived: sum of 2 quarters · filed 2018-02-27 | $11.81M derived: sum of 3 quarters · filed 2018-02-27 | $14.36M 10-K · filed 2018-02-27 |
| 2015-09-30 | $2.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $5.96M derived: sum of 2 quarters · filed 2016-11-08 | $8.51M 10-Q · filed 2016-11-08 | $10.77M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $3.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $5.69M 10-Q · filed 2016-08-08 | $7.95M derived: sum of 3 quarters · filed 2017-02-23 | $9.71M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $2.55M 10-Q · filed 2016-05-05 | $4.81M derived: sum of 2 quarters · filed 2017-02-23 | $6.57M derived: sum of 3 quarters · filed 2017-02-23 | $7.65M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $4.02M derived: sum of 2 quarters · filed 2017-02-23 | $5.10M derived: sum of 3 quarters · filed 2017-02-23 | $8.07M 10-K · filed 2017-02-23 |
| 2014-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.84M derived: sum of 2 quarters · filed 2015-11-06 | $5.81M 10-Q · filed 2015-11-06 | $8.37M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $4.05M 10-Q · filed 2015-08-07 | $6.61M derived: sum of 3 quarters · filed 2016-02-19 | $10.70M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $2.97M 10-Q · filed 2015-05-08 | $5.53M derived: sum of 2 quarters · filed 2016-02-19 | $9.62M derived: sum of 3 quarters · filed 2016-02-19 | $12.02M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $6.65M derived: sum of 2 quarters · filed 2016-02-19 | $9.05M derived: sum of 3 quarters · filed 2016-02-19 | $10.89M 10-K · filed 2016-02-19 |
| 2013-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $6.50M derived: sum of 2 quarters · filed 2014-11-06 | $8.33M 10-Q · filed 2014-11-06 | $10.29M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $4.24M 10-Q · filed 2014-08-04 | $6.20M derived: sum of 3 quarters · filed 2015-03-13 | $8.18M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $1.83M 10-Q · filed 2014-05-12 | $3.79M derived: sum of 2 quarters · filed 2015-03-13 | $5.77M derived: sum of 3 quarters · filed 2015-03-13 | $6.79M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $3.94M derived: sum of 2 quarters · filed 2015-03-13 | $4.95M derived: sum of 3 quarters · filed 2015-03-13 | $5.73M 10-K · filed 2015-03-13 |
| 2012-09-30 | $1.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $3.00M derived: sum of 2 quarters · filed 2013-11-12 | $3.77M 10-Q · filed 2013-11-12 | $4.57M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.79M 10-Q · filed 2013-08-08 | $2.59M derived: sum of 3 quarters · filed 2014-03-07 | $3.34M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $778.00K 10-Q · filed 2013-05-10 | $1.57M derived: sum of 2 quarters · filed 2014-03-07 | $2.32M derived: sum of 3 quarters · filed 2014-03-07 | $2.43M derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $793.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.54M derived: sum of 2 quarters · filed 2014-03-07 | $1.65M derived: sum of 3 quarters · filed 2014-03-07 | $1.89M 10-K · filed 2014-03-07 |
| 2011-09-30 | $752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $858.00K derived: sum of 2 quarters · filed 2012-11-05 | $1.10M 10-Q · filed 2012-11-05 | $1.46M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $345.00K 10-Q · filed 2012-08-09 | $708.00K derived: sum of 3 quarters · filed 2013-03-01 | $906.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $239.00K 10-Q · filed 2012-05-10 | $602.00K derived: sum of 2 quarters · filed 2013-03-01 | $800.00K derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $561.00K derived: sum of 2 quarters · filed 2013-03-01 | $1.75M 10-K · filed 2013-03-01 | |
| 2010-09-30 | $198.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.39M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $1.19M 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $1.14M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |